Immunis.ai

Provider of platform for the detection of cancer

placeRoyal Oak, Michigan, United States calendar_todayFounded 2012 groups10 employees language immunis.ai

Innovation

7 patent families (3 granted) — focus: Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 2,143 times.

YearFilings
20171
20201
20211
20222
20234
20245
20253
20262

Investor mix

1 investor on record; lead investors include Savitr Capital.

Investor typeCountShare
Private equity1100%
Coming soon